title: Erectile dysfunction following retropubic prostatectomy.
abstract: Prostate cancer is the most common cancer to affect men in the UK. Treatment options depend on the grade of tumour, the patient's co-existing diseases and choice of treatment. One potentially curative option is surgery, specifically a radical retropubic prostatectomy or variation thereof. As a consequence of the surgery, men commonly experience two side-effects: urinary incontinence and erectile dysfunction (ED). This paper outlines the clinical management of ED following surgery and aims to provide an overview of how to assess a man who has developed ED and discuss the various treatment options available, along with the efficacy in terms of recovery of erections.
authors: Homerton University Hospital NHS Foundation Trust, UK.
authors: Julienne
authors: J
authors: Lalong-Muh
authors: Treacy
authors: T
authors: Colm
authors: Martin
authors: M
authors: Steggall
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use; D003376:Counseling; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D006801:Humans; D008297:Male; D024802:Nurse's Role; D015917:Penile Prosthesis; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D011468:Prostatectomy / Q000009:adverse effects* / Q000379:methods; D011471:Prostatic Neoplasms / Q000451:nursing / Q000503:physiopathology / Q000601:surgery*; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D000527:Alprostadil